479 related articles for article (PubMed ID: 17382220)
21. Pharmacologic options to prevent postoperative ileus.
Yeh YC; Klinger EV; Reddy P
Ann Pharmacother; 2009 Sep; 43(9):1474-85. PubMed ID: 19602600
[TBL] [Abstract][Full Text] [Related]
22. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
[TBL] [Abstract][Full Text] [Related]
23. A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Jansen JP; Lorch D; Langan J; Lasko B; Hermanns K; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):185-93. PubMed ID: 21292169
[TBL] [Abstract][Full Text] [Related]
24. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study.
Viscusi ER; Goldstein S; Witkowski T; Andonakakis A; Jan R; Gabriel K; Du W; Techner L; Wallin B
Surg Endosc; 2006 Jan; 20(1):64-70. PubMed ID: 16333556
[TBL] [Abstract][Full Text] [Related]
25. Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
Jang J; Kwok B; Zhong H; Xia Y; Grucela A; Bernstein M; Remzi F; Hudesman D; Chen J; Axelrad J; Chang S
Dig Dis Sci; 2020 Apr; 65(4):1164-1171. PubMed ID: 31522323
[TBL] [Abstract][Full Text] [Related]
26. The effect of alvimopan on recovery after laparoscopic segmental colectomy.
Obokhare ID; Champagne B; Stein SL; Krpata D; Delaney CP
Dis Colon Rectum; 2011 Jun; 54(6):743-6. PubMed ID: 21552060
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of alvimopan following bowel resection: a comparison of two dosing strategies.
Winegar B; Cox M; Truelove D; Brock G; Scherrer N; Pass LA
Ann Pharmacother; 2013 Nov; 47(11):1406-13. PubMed ID: 24285757
[TBL] [Abstract][Full Text] [Related]
28. Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion.
Vora A; Marchalik D; Nissim H; Kowalczyk K; Bandi G; McGeagh K; Lynch J; Venkatesan K; Ghasemian R; Hwang J; Hwang MV
Can J Urol; 2014 Apr; 21(2):7222-7. PubMed ID: 24775576
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study.
Büchler MW; Seiler CM; Monson JR; Flamant Y; Thompson-Fawcett MW; Byrne MM; Mortensen ER; Altman JF; Williamson R
Aliment Pharmacol Ther; 2008 Aug; 28(3):312-25. PubMed ID: 19086236
[TBL] [Abstract][Full Text] [Related]
30. The use of alvimopan for postoperative ileus in small and large bowel resections.
Brady JT; Dosokey EM; Crawshaw BP; Steele SR; Delaney CP
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1351-8. PubMed ID: 26488223
[TBL] [Abstract][Full Text] [Related]
31. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
[TBL] [Abstract][Full Text] [Related]
32. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
Hilton WM; Lotan Y; Parekh DJ; Basler JW; Svatek RS
BJU Int; 2013 Jun; 111(7):1054-60. PubMed ID: 23171223
[TBL] [Abstract][Full Text] [Related]
33. Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use?
Wen Y; Jabir MA; Keating M; Althans AR; Brady JT; Champagne BJ; Delaney CP; Steele SR
Surg Endosc; 2017 Sep; 31(9):3483-3488. PubMed ID: 27928668
[TBL] [Abstract][Full Text] [Related]
34. Alvimopan.
Curran MP; Robins GW; Scott LJ; Perry CM
Drugs; 2008; 68(14):2011-9. PubMed ID: 18778122
[TBL] [Abstract][Full Text] [Related]
35. Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials.
Delaney CP; Senagore AJ; Viscusi ER; Wolff BG; Fort J; Du W; Techner L; Wallin B
Am J Surg; 2006 Mar; 191(3):315-9. PubMed ID: 16490538
[TBL] [Abstract][Full Text] [Related]
36. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
Saclarides TJ
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
[TBL] [Abstract][Full Text] [Related]
37. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.
Paulson DM; Kennedy DT; Donovick RA; Carpenter RL; Cherubini M; Techner L; Du W; Ma Y; Schmidt WK; Wallin B; Jackson D
J Pain; 2005 Mar; 6(3):184-92. PubMed ID: 15772912
[TBL] [Abstract][Full Text] [Related]
38. Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis.
Xu LL; Zhou XQ; Yi PS; Zhang M; Li J; Xu MQ
J Surg Res; 2016 Jun; 203(1):211-21. PubMed ID: 27338552
[TBL] [Abstract][Full Text] [Related]
39. Introduction of alvimopan into an enhanced recovery protocol for colectomy offers benefit in open but not laparoscopic colectomy.
Barletta JF; Asgeirsson T; El-Badawi KI; Senagore AJ
J Laparoendosc Adv Surg Tech A; 2011 Dec; 21(10):887-91. PubMed ID: 21939354
[TBL] [Abstract][Full Text] [Related]
40. Alvimopan addition to a standard perioperative recovery pathway.
Itawi EA; Savoie LM; Hanna AJ; Apostolides GY
JSLS; 2011; 15(4):492-8. PubMed ID: 22643504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
